News

Simple blood test is first to identify pregnant women at risk of pre-eclampsia even before any symptoms develop

January 5, 2022

The new research was conducted by a global collaborative involving experts at King’s College London, Guy’s and St Thomas’ NHS Foundation Trust, Brigham and Women’s Hospital in Boston, Massachusetts and US biotechnology firm Mirvie.

Maternal cell-free RNA can gauge preeclampsia risk months before symptoms, study finds

January 5, 2022

By comparing the cell-free RNA profiles of pregnant women with and without preeclampsia, the Mirvie-led team developed a model to predict who might develop the condition. The researchers found the model could identify three-quarters of women who would later develop preeclampsia early in their pregnancies.

New blood test could detect whether pregnant women will be affected by preeclampsia

January 5, 2022

A new blood test could detect whether pregnant women will be affected by preeclampsia, which can cause stroke, organ damage and preterm birth, months before its symptoms appear.

Simple test could predict dangerous blood pressure in pregnant women

January 5, 2022

The test would also be important because it does not depend on race (including race did not improve the predictions), but instead on what is actually happening at a biological level in that individual, the authors say.

Cell-free RNA testing for pregnancy complications

July 31, 2021

Mirvie is developing a revolutionary, cell-free RNA test using a simple blood sample to assess the risk of developing severe pregnancy complications.

Improving pregnancy health: How we can predict challenges sooner

July 12, 2021

Obstetrics has improved in treating conditions like preterm birth and preeclampsia, but the ability to predict who’s at risk is “ripe for exploration and innovation.”

Meet Mirvie, a Femtech startup creating a blood test for early detection of pregnancy complications

April 28, 2021

Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications.…

A former Grail exec and the president of the Chan Zuckerberg Biohub are developing a blood test to help expectant mothers understand the chances of pregnancy complications

April 27, 2021

With Mirvie, Quake and Jain are attempting to apply liquid biopsy technology more commonly found in oncology centers to pregnancy, a more common but significantly less funded area of research, according to Jain.

Noninvasive blood tests for fetal development predict gestational age and preterm delivery

June 8, 2018

Low-cost methods for monitoring fetal development could improve prenatal care, especially in low-resource settings. By measuring the levels of certain placental RNA transcripts in maternal blood…

10 Breakthrough Technologies 2019 – How we’ll invent the future.

February 27, 2019

We asked Gates to choose this year’s list of inventions that will change the world for the better. I was honored when MIT Technology Review invited me to be the first guest curator of its 10 Breakthrough Technologies…

Read up on our latest news

Featured Story

Media Coverage